There are three main technologies under development by Quintain NS, for a wide range of applications in human and animal health:
|
|
This technology aims to produce a fast, cost-effective detection method for Meningococcal disease by applying nanoparticle technology to provide a rapid readout.
|
|
Read more...
|
|
|
Quintain NS is launching a major investment into the development of novel, nanoengineered contrast reagents for the early detection of disease states such as CVD, neurological disorders and cancer. |
|
Read more...
|
|
|
Nanoarray Diagnostic Biochips offer a fast, convenient and accurate method for detecting specific chemical or biological entities, particularly related to infectious or toxic molecules such as protein markers. In the pharmaceutical industry applications include drug discovery, DNA analysis and protein diagnostics.
|
|
Read more...
|
|
|